Michael Rutten, Ph.D.
Phone: 503 418-0092
Office: HRC 6D09H
Dr. Rutten received his PhD degree from the University of California, Berkeley, with a Postdoctoral Fellowship at UCLA, and a Research Fellowship at Harvard Medical School. Dr. Rutten’s background includes training in primary cell isolation and culture techniques, intracellular pH and calcium signaling, membrane ion transport, and immunofluorescence and confocal microscopy.
He has previously held positions at the University of Kansas Medical Center, the Portland VA Medical Center/OHSU and the Oregon Medical Laser Center at Providence St. Vincent Medical Center. Dr. Rutten is currently a Senior Scientist at the OHSU Center for Regenerative Medicine, and is part of Dr. Kenton Gregory’s Cell Therapy team.
His current research activities on the Cell Therapy team involve the use of adult autologous stem cells for the treatment of damaged heart and skeletal muscle tissues. Other studies he is involved with include the development of functional Schwann-like cells from autologous bone marrow cells with the intention of using them in pre-clinical studies for the treatment of damaged peripheral nerves. He is also working with Dr. Cynthia Gregory and the Cell Therapy team on research using allogeneic mesenchymal stromal cells to treat lung disease. Dr. Rutten also has research interests in using ECIS (Electric Cell-substrate Impedance Sensing) technology for developing a device that could be used to test stem cell functionality/potency. The goal of this work would be to use this device for clinical regenerative medicine studies and for high-throughput-testing (HTS) of drugs on stem cells in the pharmaceutical industry.